Aridis Pharmaceuticals Enrolls First COVID-19 Patient in Phase III Study for Patients on Mechanical Ventilators with ‘Superinfection’

Aridis Pharmaceuticals Enrolls First COVID-19 Patient in Phase III Study for Patients on Mechanical Ventilators with ‘Superinfection’

Aridis Pharmaceuticals, Inc (NASDAQ: ARDS) announced the enrollment of its first COVID-19 patient in an ongoing Phase III clinical trial of its investigational AR-301, a monoclonal antibody against S. aureus induced pneumonia in patients who were already on mechanical...

Pin It on Pinterest